Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04888624 · ClinicalTrials.gov registry record · NA

A Comparison Between Two Post-operative Dressings

A NA study, sponsored by SerenaGroup.

Completed
Registry status
NA
Development phase
20
Enrollment target

NCT04888624: Completed NA study, sponsored by SerenaGroup.

NCT04888624 is a NA study that has completed, run by SerenaGroup. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04888624, a NA study, has completed, sponsored by SerenaGroup.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

Surgical site infections are one of the leading causes of post-operative morbidity and mortality worldwide. The ideal post-operative dressing is impermeable and remains intact preventing contamination of the incision with microorganisms. In addition, it is often difficult for the patient to identify breaks in dressing integrity. This trial compares a post-operative dressing (DrySee® Inc. Houston Tx) with moisture detection allowing the patient to recognize when the dressing is compromised to a standard post-operative dressing (Tegaderm® + Pad, 3M, St. Paul, MN). The ideal dressing also allows the patient to shower without removing the dressing.

Primary Outcome

A comparison of wear time between the two post-operative dressings under study.

Interventions

  • DEVICE DrySee® dressing with moisture detection
  • DEVICE Tegaderm® + Pad transparent film dressing

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2021-09-13
Est. Completion 2022-02-01
Phase NA
SerenaGroup

10 total trials

What the finished NCT04888624 record still lists

NCT04888624 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which DrySee® dressing with moisture detection is the first listed.

NCT04888624 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04888624 about?

NCT04888624 is a clinical study titled "A Comparison Between Two Post-operative Dressings". Surgical site infections are one of the leading causes of post-operative morbidity and mortality worldwide. The ideal post-operative dressing is impermeable and remains intact preventing contamination of the incision with microorganisms. In addition, it is often difficult for the patient to identify...

What is the current status of trial NCT04888624?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2021-09-13. Estimated completion is 2022-02-01.

What interventions are being tested in trial NCT04888624?

The interventions under investigation include: DrySee® dressing with moisture detection (DEVICE), Tegaderm® + Pad transparent film dressing (DEVICE).

Who is sponsoring clinical trial NCT04888624?

This trial is sponsored by SerenaGroup, which has 10 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04888624's enrollment target sits among peer trials

20 1768th of 2000 higher than 140 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04888624, the US trial registry maintained by the National Library of Medicine. NCT04888624 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.